Home › Funds › SNYDER CAPITAL MANAGEMENT L P › TECH
SNYDER CAPITAL MANAGEMENT L P position in TECH
BIO-TECHNE CORP · Health Care
SNYDER CAPITAL MANAGEMENT L P reported holding 3,163,816 shares of TECH (BIO-TECHNE CORP) in its Q2 2026 13F filing — a position valued at US$223.5M, representing 3.86% of its reported portfolio and ranking #4 among its reported holdings. SNYDER CAPITAL MANAGEMENT L P has disclosed TECH holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How SNYDER CAPITAL MANAGEMENT L P's TECH position evolved
SNYDER CAPITAL MANAGEMENT L P first disclosed a stake in TECH in Q3 2023 at 126,832 shares (US$8.6M). The position peaked in Q2 2026 at 3,163,816 shares, worth US$223.5M. Across 12 filings, SNYDER CAPITAL MANAGEMENT L P increased the stake 9 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 3,163,816 shares valued at US$223.5M — an increase of 1,281,518 shares quarter over quarter.. Notable position changes include a 661% increase in Q4 2023 (shares fell 9% over the following quarter), a 29% increase in Q3 2025 (shares rose 6% over the following quarter), a 68% increase in Q2 2026 (shares rose 3% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 126.83K | $8.63M | New |
| Q4 2023 | 964.96K | $74.46M | Add |
| Q1 2024 | 1.02M | $71.98M | Add |
| Q2 2024 | 1.00M | $71.91M | Reduce |
| Q3 2024 | 1.06M | $85.03M | Add |
| Q4 2024 | 1.13M | $81.21M | Add |
| Q1 2025 | 1.23M | $71.91M | Add |
| Q2 2025 | 1.33M | $68.66M | Add |
| Q3 2025 | 1.72M | $95.64M | Add |
| Q4 2025 | 1.93M | $113.32M | Add |
| Q1 2026 | 1.88M | $98.37M | Reduce |
| Q2 2026 | 3.16M | $223.52M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About TECH and 13F data
TECH (BIO-TECHNE CORP) is a Health Care company. 28 other funds we track also report a position in TECH — the largest reported positions include HBK INVESTMENTS L P (US$482.2M), Ruane Cunniff & Goldfarb (Sequoia) (US$236.6M), MAIRS & POWER INC (US$190.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding TECH
- HBK INVESTMENTS L P 6.83M sh · $482.19M · Q2 2026
- Ruane Cunniff & Goldfarb (Sequoia) 3.35M sh · $236.60M · Q2 2026
- MAIRS & POWER INC 2.70M sh · $190.80M · Q2 2026
- WHITEBOX ADVISORS LLC 2.10M sh · $148.37M · Q2 2026
- RGM Capital, LLC 2.15M sh · $126.56M · Q4 2025
More on SNYDER CAPITAL MANAGEMENT L P
FAQ
How long has SNYDER CAPITAL MANAGEMENT L P held TECH?
SNYDER CAPITAL MANAGEMENT L P has disclosed TECH holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
What is SNYDER CAPITAL MANAGEMENT L P's current position in TECH?
As of Q2 2026, SNYDER CAPITAL MANAGEMENT L P holds 3.16M shares of TECH (BIO-TECHNE CORP), valued at $223.52M, representing 3.86% of its reported portfolio and ranking #4.
Has SNYDER CAPITAL MANAGEMENT L P been buying or selling TECH?
In the latest 13F filing (Q2 2026), SNYDER CAPITAL MANAGEMENT L P increased its position in TECH. The position peaked in Q2 2026 at 3.16M shares.
Which other funds hold TECH?
Other major institutional holders of TECH include HBK INVESTMENTS L P, Ruane Cunniff & Goldfarb (Sequoia), MAIRS & POWER INC, among 28 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.